Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs Aspirin in Pediatric Fontan Procedure (UNIVERSE)
NCT02846532Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2016
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of rivaroxaban in thrombosis, sponsored by Janssen Pharmaceutical. Started Nov 2016; status: completed.
02
Drugs
rivaroxaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT02846532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02846532.